Related Experiment Videos
Alloreactivity as a source of high avidity peptide-specific human CTL
1Department of Immunology, Institute for Cell Biology, University of Tübingen, Germany.
Journal of Immunology (Baltimore, Md. : 1950)
|January 14, 1999
Summary
Generating cytotoxic T lymphocytes (CTL) against specific MHC class I molecules is possible even without positive selection. However, positive selection enhances CTL frequency and avidity, crucial for tumor immunotherapy.
Area of Science:
- Immunology
- Molecular Biology
- Cellular Biology
Background:
- Cytotoxic T lymphocytes (CTL) play a crucial role in adaptive immunity, recognizing foreign and self-peptides presented by MHC class I molecules.
- Positive selection during T cell development shapes the T cell repertoire, but its absolute necessity for generating MHC-restricted CTL is debated.
Purpose of the Study:
- To investigate the generation and characteristics of allorestricted CTL stimulated with peptide libraries.
- To determine if CTL restricted to a specific MHC class I molecule can be generated without positive selection by that molecule.
- To assess the potential of this method for isolating high-avidity CTL for immunotherapy.
Main Methods:
- Peripheral blood lymphocytes (PBL) from HLA-A2 or HLA-A3 donors were stimulated with synthetic peptide libraries.
- Peptides were presented on HLA-A2 or HLA-A3 expressing TAP-deficient cells.
- Allorestricted CTL responses were analyzed for frequency, peptide dependency, and specificity.
Main Results:
- Allorestricted CTL specific for peptide libraries constituted up to half of the alloreactive CTL response.
- These CTL occurred at a twofold lower frequency compared to autologous peptide library-specific CTL.
- A representative CTL clone (10F4) demonstrated high peptide avidity, indicating successful stimulation of potent CTL.
Conclusions:
- Positive selection is not essential but enhances the frequency of MHC class I-restricted CTL.
- The described in vitro stimulation method can generate CTL with varying peptide avidities.
- This approach holds promise for isolating CTL with therapeutic potential for tumor immunotherapy.